5 completed, 1 active not recruiting, 1 terminated. 7 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Active not recruiting 1, Terminated 1 |
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Tay-Sachs Disease: new trials by email Literature Review of Tay-Sachs Disease trials Research Report on Tay-Sachs Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis TSHA-101 - Infantile GM2 Gangliosidosis (Disorder) | Phase 1 / Phase 2 | Active not recruiting | Dr. Anupam Sehgal | 3 | 2021-03-12 | 2023-05-09 |
| N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease) IB1001 - GM2 Gangliosidosis, Tay-Sachs Disease | Phase 2 | Completed | IntraBio Inc | 30 | 2019-06-07 | 2024-03-12 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome | Phase 1 / Phase 2 | Terminated | Talaris Therapeutics Inc. | 3 | 2011-04-01 | 2023-04-12 |
| Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease) Pyrimethamine, Leucovorin - Gangliosidoses, GM2, Sandhoff Disease | Phase 1 / Phase 2 | Completed | The Hospital for Sick Children | 20 | 2009-08-01 | 2012-02-23 |
| HSCT for High Risk Inherited Inborn Errors Clofarabine, Total body Irradiation, Melphalan - Adrenoleukodystrophy, Metachromatic Leukodystrophy | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 38 | 2006-09-01 | 2019-07-11 |
| Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis miglustat - Gangliosidoses GM2 | Phase 2 | Completed | The Hospital for Sick Children | 5 | 2004-07-01 | 2016-05-19 |
| Stem Cell Transplant for Inborn Errors of Metabolism Stem Cell Transplant, Busulfan, Cyclophosphamide, Antithymocyte Globulin - Adrenoleukodystrophy, Metachromatic Leukodystrophy | Phase 2 / Phase 3 | Completed | Masonic Cancer Center, University of Minnesota | 135 | 1995-01-01 | 2017-12-28 |
Sandhoff Disease (7) · Gangliosidoses, GM2 (4) · Adrenoleukodystrophy (3) · Leukodystrophy, Globoid Cell (3) · Leukodystrophy, Metachromatic (3) · Gangliosidosis, GM1 (2) · Mucopolysaccharidosis III (2) · Niemann-Pick Diseases (2) · Wolman Disease (2) · Fucosidosis (1) · Gaucher Disease (1) · Lysosomal Storage Diseases (1) · Metabolism, Inborn Errors (1) · Mucolipidoses (1)
Brain Diseases (7) · Brain Diseases, Metabolic (7) · Brain Diseases, Metabolic, Inborn (7) · Central Nervous System Diseases (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Gangliosidoses (7) · Genetic Diseases, Inborn (7) · Lipid Metabolism Disorders (7) · Lipid Metabolism, Inborn Errors (7) · Lipidoses (7) · Lysosomal Storage Diseases, Nervous System (7) · Metabolic Diseases (7) · Nervous System Diseases (7) · Nutritional and Metabolic Diseases (7) · Sphingolipidoses (7)
Stem Cell Transplantation (2) · Alemtuzumab (1) · Antilymphocyte Serum (1) · Bone Marrow Transplantation (1) · Busulfan (1) · Clofarabine (1) · Cyclophosphamide (1) · Hematopoietic Stem Cell Transplantation (1) · Hydroxyurea (1) · IB1001 (1) · Leucovorin (1) · Melphalan (1) · Pyrimethamine (1) · Whole-Body Irradiation (1) · acetylleucine (1)
Masonic Cancer Center, University of Minnesota (2) · The Hospital for Sick Children (2) · Dr. Anupam Sehgal (1) · IntraBio Inc (1) · Talaris Therapeutics Inc. (1)
United States (4) · Canada (3) · Germany (1) · Spain (1) · United Kingdom (1)
Paul Orchard, MD (2) · Anupam Sehgal, MBBS (1) · Joe T Clarke, MD (1) · Joe TR Clarke, MD (1) · Suzanne T Ildstad, MD (1)
PMID 21586746, PMID 19595619, PMID 33482890, PMID 34349180, PMID 36456200, PMID 38205442, PMID 42467089